C. Sophia Albott, MD, MA

I received a BA in Neuroscience from Grinnell College in Iowa and then graduated with a BA and a Masters in Philosophy from the Catholic University of Leuven in Belgium. I completed medical school here at the University of Minnesota, where I also did my residency in psychiatry, and my T32 postdoctoral fellowship in psychiatric comorbidity.

I am an adult psychiatrist with a clinical focus on neuromodulation, deep transcranial magnetic stimulation (dTMS), treatment-resistant depression, mood disorders, translational neuroscience, women's mental health, and comorbid psychiatric disorders. My research focuses on investigating novel treatments and diagnostic tools for characterizing pathological responses to trauma, which focuses on post traumatic stress disorder and depression.

I am board certified by the American Board of Psychiatry & Neurology and a member of the American Society of Hispanic Psychiatry. Within the Department of Psychiatry and Behavioral Sciences, I am the deputy vice-chair for research. I am also co-founder of the Junior Research Faculty Peer Mentoring Group and the Early Career Investigator Peer Mentoring Group.

• 2017 Career Development Institute for Psychiatry, Class of 2017
• 2017 Society for Biological Psychiatry Chair’s Choice Award
• 2015 APA Research Colloquium Junior Investigator Award
• 2015 ASCP Fellowship for Workshop on Clinical Trials in Psychopharmacology
• 2013 Harold Lawn Resident Teacher of the Year Award

• American Society of Hispanic Psychiatry, 2016-present
• Anxiety and Depression Association of America (ADAA), 2014-present
• American Society of Clinical Psychopharmacology (ASCP), 2014-present
• Association of Women Psychiatrists, 2013-present
• American Psychiatric Association (APA), 2011-present
• Minnesota Psychiatric Society (MPS), 2011-present
• American Medical Association (AMA), 2005-present 

Dr. Albott investigates novel treatments and diagnostic tools for characterizing pathological responses to trauma, with a focus on post-traumatic stress disorder and depression. She is specifically interested in using both pharmacological and neuromodulation interventions for understanding response and relapse to effective treatments using multimodal analytic methodologies.

Albott CS, Shiroma PR, Cullen K, Johns B, Thuras P, Wels J, Lim KO. The Antidepressant Effect of Repeated Dose Intravenous Ketamine is Delayed by Concurrent Benzodiazepine Use. J Clin Psych. In Press .

Shiroma PR, Albott CS, Johns B, Thuras P, Wels J, Lim KO. The Effect of Repeated Ketamine Infusion over Facial Emotion Recognition in Treatment-Resistant Depression: A Preliminary Report. Journal of Neuropsychiatry and Clinical Neurosciences, Feb 6:appineuropsych14100243. [Epub ahead of print]

Shiroma PR, Albott CS, Johns B, Thuras P, Wels J, Lim KO. Neurocognitive Performance and Serial Intravenous Subanesthetic Ketamine in Treatment-resistant Depression. International Journal of Neuropsychopharmacology, 2014 Jun 25:1-9.

Shiroma PR, Johns B, Kuskowski M, Wels J, Thuras P, Albott CS, Lim KO. Augmentation of Response and Remission to Serial Intravenous Subanesthetic Ketamine in Treatment Resistant Depression. Journal of Affective Disorders, 2014 Feb;155:123-9.